Tech Center 1600 • Art Units: 1600 1632 1671 1672
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18031163 | T-CELL VACCINE FOR SARS VIRUS | Non-Final OA | THE JOHNS HOPKINS UNIVERSITY |
| 17997791 | MODIFIED ADENO-ASSOCIATED VIRUS VECTORS THAT EVADE NEUTRALIZING ANTIBODIES AND USES THEREOF | Non-Final OA | The University of North Carolina at Chapel Hill |
| 17928255 | ADJUVANTS FOR SEVERE ACUTE RESPIRATORY SYNDROME-RELATED CORONAVIRUS (SARS-COV) VACCINES | Non-Final OA | Children's Medical Center Corporation |
| 18301542 | TREATMENT OF INFLAMMATORY CONDITIONS | Non-Final OA | Kyoto University |
| 18552635 | DNA Encoded Nanoparticle Vaccine Against Human Papillomavirus, and Methods of Use Thereof | Non-Final OA | The Wistar Institute of Anatomy and Biology |
| 18262073 | Therapeutic Viral Vaccine | Non-Final OA | GlaxoSmithKline Biologicals SA |
| 18493787 | ONCOLYTIC VIRUS COMBINED WITH CAR T CELLS FOR ANTI-TUMOR THERAPY | Non-Final OA | Joint BioScinces |
| 18546690 | INFLUENZA VIRUS DEFECTIVE INTERFERING PARTICLES FOR USE IN THE PROPHYLACTIC OR THERAPEUTIC TREATMENT OF CORONAVIRIDAE INFECTION | Non-Final OA | Otto-von-Guericke-Universität Magdeburg |
| 18350357 | FOAM VACCINATION OF AVIANS | Non-Final OA | UNIVERSITY OF DELAWARE |
| 18030480 | METHOD FOR DETECTION OF RNA OR DNA FROM BOLOGICAL SAMPLES | Non-Final OA | MATERIALS AND MACHINES CORPORATION OF AMERICA |
| 18038665 | METHODS OF TREATING SARS-COV-2 INFECTIONS | Non-Final OA | HAMAD MEDICAL CORPORATION |
| 18037226 | MULTICISTRONIC RNA VACCINES AND USES THEREOF | Non-Final OA | SEQIRUS INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy